SLC1A5 and posterior cortical atrophy: The expression of ASCT2 intensifies in patients with recurrent PCa post-ADT (26), ASCT2 is notably overexpressed in cancerous prostate cells and inhibiting ASCT2 could impair the tumor cell growth and development of metastases in PCa xenografts models (26).